Related Experiment Video
Updated: Jun 26, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Intracerebral hemorrhage
Lucas Elijovich1, Pratik V Patel, J Claude Hemphill
1Department of Neurology, University of California-San Francisco, San Francisco General Hospital, 1001 Potrero Avenue, San Francisco, CA 94110, USA.
Insights
Intracerebral hemorrhage (ICH) is a severe stroke type with high mortality. Research explores its causes, predictors, and potential treatments like surgical evacuation and blood pressure management.
Area of Science:
- Neurology
- Neurosurgery
- Stroke Medicine
Background:
- Intracerebral hemorrhage (ICH) constitutes 10-15% of strokes, leading to significant morbidity and mortality.
- While hypertension is a primary cause, other factors include cerebral amyloid angiopathy, drug abuse, and vascular anomalies.
- Predictors of poor outcomes include low Glasgow Coma Scale score, large hematoma volume, intraventricular hemorrhage, infratentorial location, and advanced age.
Purpose of the Study:
- To review current understanding of intracerebral hemorrhage (ICH) causes, outcomes, and treatment strategies.
- To highlight recent advancements in clinical trials for ICH management.
- To discuss emerging insights into the mechanisms of brain injury following ICH.
Main Methods:
- Review of existing literature on intracerebral hemorrhage (ICH).
- Analysis of data from recent large clinical trials on surgical and medical interventions.
- Examination of basic research into the pathophysiology of perihematoma injury.
Main Results:
- Hematoma expansion is a common occurrence in ICH, irrespective of coagulopathy.
- Perihematoma injury may result from blood and iron toxicity (neurohemoinflammation) rather than ischemia.
- Clinical trials indicate feasibility of both surgical and medical treatments for ICH.
Conclusions:
- Current ICH guidelines focus on blood pressure control, coagulopathy correction, and surgery for cerebellar bleeds.
- Ongoing trials are evaluating surgical evacuation techniques and intensive blood pressure lowering.
- Further research is crucial for developing effective treatments to improve ICH outcomes.
Abstract:
Intracerebral hemorrhage (ICH) accounts for 10 to 15% of all strokes, but results in a disproportionately high morbidity and mortality. Although chronic hypertension accounts for the majority of ICH, other common causes include cerebral amyloid angiopathy, sympathomimetic drugs of abuse, and underlying cerebral vascular anomalies. Validated baseline predictors of clinical outcome after ICH include the Glasgow Coma Scale score, hematoma volume, presence and amount of intraventricular hemorrhage, infratentorial ICH location, and advanced age. Although no treatment of proven benefit currently exists for ICH, several recent large clinical trials have demonstrated the feasibility of surgical and medical treatments for ICH. Clinical research into ICH mechanisms of injury has demonstrated that hematoma expansion is common, even in patients without coagulopathy. Basic research has suggested that perihematoma injury is more likely related to toxicity of blood and iron in the brain ("neurohemoinflammation") rather than primary ischemic injury. Current guidelines for ICH treatment emphasize blood pressure management, urgent and rapid correction of coagulopathy, and surgery for cerebellar ICH. Ongoing clinical trials are investigating surgical evacuation of lobar hemorrhage, minimally invasive surgical hematoma evacuation, and aggressive blood pressure lowering.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Increased Intracranial Pressure ll: Pathophysiology
Increased Intracranial Pressure l: Introduction
Cerebral Edema l: Introduction
